AL002

Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Fierce Biotech
Tue, 11/26/24 - 11:05 am
Alector
AbbVie
Alzheimer's disease
clinical trials
layoffs
AL002